Cognition Disorders

The grounding supports multiple contributing causes rather than a single aetiology. These include Alzheimer disease neuropathologic changes such as beta-amyloid plaques and neurofibrillary tangles, as well as non-AD brain lesions and white matter hyperintensities that can alter cognition independently of Alzheimer disease.

The literature links cognitive impairment to underlying brain pathology and altered neural systems supporting cognition. Reported mechanisms include amyloid beta-peptides and tau pathology, cholinergic system degeneration with loss of forebrain cholinergic innervation, and changes in neuronal plasticity and brain-behavior function.

Older age is implied by the literature on age-related cognitive decline and cognitive impairment in the elderly. White matter hyperintensities are associated with increased risk of cognitive decline and dementia, and mild cognitive impairment or subjective cognitive decline are described as early abnormal cognitive states that may precede dementia.

The grounding does not support a single disease-specific standard treatment for cognition disorders. The literature instead emphasizes assessment and research tools such as neuropsychological tests, mental status schedules, psychiatric status rating scales, and non-invasive brain stimulation as a clinical and research modality studied in cognition and related disorders.